Nuclear Medicine Innovation1

[WP-28-10] High brain permeability for 11C-labeled peretinoin, guiding to expose drug's novel CNS activity

Keiichi Suzuki¹、Hiroko Koyama^1,2、Aya Ogata³、Yasuyuki Kimura³、Hideki Ishii⁴、Yuji Nagai⁴、Hiroshi Katsuki⁵、Tetsuya Kimura⁶、Takashi Kato³、Masaaki Suzuki³ (1.United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University、2.Faculty of Engineering, Gifu University、3.National Center for Geriatrics and Gerontology、4.National Institutes for Quantum and Radiological Science and Technology、5.Graduate School of Pharmaceutical Sciences School of Pharmacy, Kumamoto University、6.Tokyo Metropolitan Institute of Gerontology)